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Abstract - Mast cell (MC) active mediators promote inflammation through changes induced in the connective tissue com-
ponents of human gingiva. The aim of this study was to evaluate the distribution, mast cell density and their relationship 
with the degree of inflammatory infiltrate in gingiva from patients with periodontal disease. Thirty-nine cases with peri-
odontal disease and 12 cases without significant changes to the gingival mucosa were investigated. MCs were identified on 
paraffin-embedded specimens by immunohistochemistry using anti-mast cell tryptase. The inflammatory infiltrate was 
scored from 0 to 3, and the MCs were counted using the hotspot method. Intraepithelial MCs were scored from 0 to 2. 
We found a significant increase of mast cell density in cases with mild and moderate inflammatory changes, and a slight 
decrease in patients with severe periodontal disease. We noticed a higher degranulation rate in patients with periodontal 
disease compared to those with healthy mucosa. Intraepithelial MCs were found in cases with periodontal disease only 
and were correlated with the severity of the inflammatory lesion. MCs are important cellular components of the early 
stages of periodontal disease. Contrary to other studies, we found that MC density and activation increases with moderate 
inflammation but decreases in severe inflammatory lesions. Our data suggest that MCs are key players in the progression 
of inflammatory lesions of the gingiva. In advanced-stage periodontal disease, intraepithelial MCs apparently play an im-
portant role, although their biological significance remains to be fully understood.
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INTRODUCTION
Mast  cells  (MCs)  are  connective  tissue  resident 
cells found in almost all human organs. In normal 
conditions, MCs release specific mediators that act 
on several connective tissue components as ground 
substance, blood vessels or nerve endings. In ad-
dition,  the  MC  membrane  has  a  relatively  large 
spectrum of receptors capable of mediating the in-
teraction with components of the immune system 
and thus they are considered to play an important 
role in human immunity. It has been demonstrated 
that MCs are a powerful source of growth factors, 
such as vascular endothelial growth factor or nerve 
growth factor. Dramatic changes in the number, 
structure and active mediator content of specific 
granules were reported in several pathologic con-
ditions. MC involvement in allergic diseases patho-
genesis is well known, their behavior and clinical 
consequences  being  almost  similar  with  regard 
to the stimulation of cytoplasmic granule release. 
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was shown many years ago, but their role in tumor 
progression and metastasis is still controversial. A 
significant increase in their number was detected in 
the early stages of oral cavity squamous cell carci-
noma and a dramatic decrease in advanced-stages 
of carcinoma, as well as in less differentiated tumors 
(Cheema et al., 2012). However, in many human 
tumors  an  MC-induced  angiogenesis  was  clearly 
demonstrated, which finally contributes to tumor 
progression  (Michailidou  et  al.,  2012;  Jahanshahi 
and Sabaghian, 2012). Therefore, at present it is dif-
ficult to conclude if mast cell density (MCD) reflects 
a good or poor prognosis; it most probably suggest 
a particular phenotype in terms of biological me-
diators. These findings lead to the concept of MC 
heterogeneity that recognizes many subtypes, based 
particularly on the content in mast cell tryptase and 
mast cell chymase.
Chronic inflammation is a good model to in-
vestigate the MC reaction as a response to minimal 
stimuli. Local activation of MCs is usually associated 
with an accumulation of lymphocytes, macrophages 
and plasma cells. Frequently this heterogeneous in-
filtrate is concentrated around blood vessels. Recent-
ly, the mast cell activation syndrome was described, 
characterized by systemic symptoms that involve a 
minimum of two organs, but most frequently the mu-
cosa of the digestive tract and the skin (Frieri et al., 
2013; Valent, 2013). Mast cell activation syndrome is 
a rare disorder (Picard et al., 2013), but local activa-
tion of MCs is a frequent event and even a condition 
of inflammation.  
MCs were described some time ago in the mu-
cosa of the oral cavity and particularly in human gin-
giva (Zachrisson, 1967) and experimental gingivitis 
(Zachrisson, 1969). As in many other locations in 
the human body, their intrinsic role in the gingiva is 
still elusive in both normal and pathological condi-
tions. In periodontal disease, and particularly gingi-
vitis, the mast cell density significantly increases, but 
without an explanation regarding their involvement 
in the maintaining or progression of inflammation 
(Lagdive et al., 2013). Moreover, there are no data on 
the relationship between MCs and the density of the 
inflammatory infiltrate. A recent study has shown a 
correlation between MC degranulation and the se-
verity of periodontitis (Huang et al., 2013). It was 
found that the density of degranulated tryptase-pos-
itive MCs is significantly higher in severe periodon-
titis compared to moderate periodontitis and nor-
mal tissue. However, it was not possible to conclude 
if degranulation was induced by the inflammatory 
infiltrate or a degranulation-induced accumulation 
of inflammatory cells. Moreover, increased mast cell 
density was reported by many authors in periodontal 
disease, but results are conflicting probably in part 
due to different counting methods and the relatively 
low number of cases (Steinsvoll et al., 2004; Batista 
et al., 2005).
In the present paper, we describe our investiga-
tion of MC distribution, density and relationships 
with other cells of the inflammatory tissue of the gin-
giva, including the particular aspect of intraepithelial 
MCs presence. 
MATERIALS AND METHODS
Patients
Twelve patients without significant changes to the 
oral mucosa, 15 patients with mild, 16 with mod-
erate and 8 with severe inflammatory lesions of the 
gingiva as found by the clinical examination were in-
vestigated. A biopsy was taken from each patient and 
washed with buffer saline. The local research ethics 
committee approved the protocol of the study and 
informed consent was obtained from all subjects ac-
cording to the World Medical Association Declara-
tion of Helsinki.
Primary processing
Gingival biopsies were fixed in buffered formalin and 
embedded in paraffin, using the standard histologi-
cal procedure. Five-micrometer thick sections were 
obtained from each case and they were stained with 
the routine hematoxylin-eosin method. These slides 
were used to analyze the morphological changes of 
the  epithelium  and  to  evaluate  the  density  of  the MAST CELLS IN PERIODONTAL DISEASE 803
inflammatory infiltrate. Additional slides were pre-
pared for the immunohistochemical study. 
Immunohistochemistry
MCs were detected with anti-mast cell tryptase anti-
body (clone AA1, Dako Glostrup, Denmark). Briefly, 
we  performed  heat-induced  epitope  retrieval  with 
citrate buffer (pH 6.0) (Novocastra, Newcastle upon 
Tyne, UK) for 30 min. Endogenous peroxidase was 
blocked with 3% hydrogen peroxide and followed by 
incubation with the primary antibody for 30 min. 
The Bond Polymer Refine Detection System (Leica 
Biosystems, Newcastle upon Tyne, UK) was used to 
develop the immunohistochemical reaction and the 
final product was visualized with 3,3’ diaminoben-
zidine  dihydrochloride.  Nuclei  were  stained  with 
hematoxylin.  The  full  immunohistochemical  pro-
cedure was performed with Leica Bond-Max (Leica 
Biosystems, Newcastle upon Tyne, UK) autostainer.
Scoring
The inflammatory infiltrate was scored as 0 (absent), 
+1 (isolated inflammatory cells, less than 10, +2 (ag-
gregates of inflammatory cells in the lamina propria 
only), and +3 (aggregates of inflammatory cells in 
the  lamina  propria  associated  with  intraepithelial 
lymphocytes). Counting of mast cell in the lamina 
propria  was  based  on  the  hotspot  method.  Three 
hotspot areas with high density of MCs were chosen 
at low power magnification. The MCs were counted 
at 400x magnification. The arithmetical mean of the 
three hotspots was the final result. Tryptase-positive 
granules scattered in the intercellular space were not 
taken into account to evaluate mast cell density. De-
granulated MCs were expressed as a percentage from 
the total number of MCs. Intraepithelial mast cells 
were scored at 400x magnification as follows: absent 
scored with 0, rare scored with 1 (1-2/field) and nu-
merous scored with 2 (3 or more/field).
Statistical analysis
Statistical analysis was performed with the commer-
cially  available  SPSS13.0  soft  and  Microsoft  Excel 
2010 soft. The relationships between the density of 
the inflammatory infiltrate, mast cell density in the 
lamina propria and intraepithelial MCs were evalu-
ated, applying Spearman’s test, and values of p<0.05 
were considered statistically significant.
RESULTS
Microscopically, in normal gingiva (n=12) we found 
no inflammatory changes except in one case, and 
the covering epithelium showed parakeratosis. MCs 
were found in the lamina propria, usually close to 
blood vessels and rarely in the vicinity of the epi-
thelium. The mast cell density ranged between 12 
and 31, with an average of 20.12. Degranulation was 
noticed in all of these cases. No intraepithelial MCs 
were found in cases without inflammatory infiltrate. 
We found inflammatory changes in 39 out of 51 pa-
tients. The inflammatory infiltrate consisted mainly 
of lymphocytes, neutrophilic granulocytes and mac-
rophages,  and  more  rarely  contained  eosinophilic 
granulocytes and plasma cells. Small islands of epi-
thelial cells sequestrated in the lamina propria were 
noticed, particularly in the cases with severe inflam-
matory lesions. We observed focal necrosis only in 
cases with high density of neutrophilic granulocytes. 
Based on the scoring system for the inflammatory 
infiltrate, we found 12 cases scored 0; 17 cases +1; 
9 cases +2; 13 cases +3. The microscopic features of 
the normal gingiva, mild, moderate and severe peri-
odontal disease are shown in Fig. 1.
Tryptase-positive MCs were identified in all of 
the cases included in the present study. They were 
medium-sized, with or without scattered granules in 
the pericellular space, signifying degranulation. In 
the gingiva without inflammatory changes we found 
a mast cell density of 20.12/high power field with a 
low rate of degranulation. MCs were preferentially 
located in the perivascular space and no intraepithe-
lial MCs were noticed.
In cases with mild inflammation of the gingiva, 
we found a significant increase of mast cell density. 
MCs were diffusely distributed in the lamina propria, 804 RAMONA AMINA POPOVICI ET AL.
they were not restricted to the perivascular space and 
showed a high rate of degranulation. Small aggregates 
of MCs were observed in close to the epithelium and 
intraepithelial MCs were found in 6 out of 17 cases. 
The assessed mast cell density in this group had an 
average of 44.08 MCs/high power field. 
In the group with moderate inflammation, the 
average value for mast cell density was 63.87, and 
ranged between 42 and 97 per high power field. Nu-
merous MCs were observed in the immediate vicin-
ity of the epithelium and concentrated in the areas 
with dense inflammatory infiltrate. Strong degranu-
lation was detected in almost all of the cases of this 
group. Intraepithelial MCs were found in 5 out of 9 
cases, and we observed tryptase-positive cells even 
in the intermediate and superficial layers of the epi-
thelium.
In cases with severe inflammation, we found a 
significant decrease in the value of mast cell density 
in comparison with moderate (p<0.0001) and mild 
inflammation of the gingiva (p<0.023). In these cases, 
MCs were located predominantly in the connective 
extensions of the lamina propria into the epithelium. 
We noticed an increased number of intraepithelial 
MCs that were identified in 12 of 13 cases, and half 
of the cases were scored as +2, with more than 3 in-
traepithelial MCs per high power field. 
We found the highest value of mast cell density 
in  periodontal  disease  with  moderate  inflamma-
tion and the lowest in cases with severe inflamma-
tion. Overall, the mast cell density in the gingiva of 
patients was 53.96, and compared with the gingiva 
without  inflammatory  infiltrate,  the  increase  was 
significant (p<0.0001). The relationship between the 
Fig. 1. Gingiva without inflammatory changes (a – at 200x magnification). Scattered inflammatory cells in the lamina propria (b – 200x); 
aggregates of inflammatory cells restricted to the lamina propria (c – 400x). Inflammatory cells in the lamina propria and within the 
epithelium (d – 400x). Hematoxylin and eosin staining.MAST CELLS IN PERIODONTAL DISEASE 805
number of MCs and the density of the inflammatory 
infiltrate  was  particularly  significant  for  mild  and 
moderate  inflammation  of  the  gingiva  (p<0.002), 
followed by severe inflammatory changes (p<0.027). 
On the other hand, intraepithelial MCs correlated 
with the severity of the inflammatory changes in all 
cases with periodontal disease. Data on the micro-
scopic evaluation of the inflammatory infiltrate and 
mast cell density are shown in Table 1. Degranula-
tion of MCs was a common finding in all of the cases 
and we noticed a higher rate of degranulated MCs in 
cases with periodontal disease, although we did not 
Fig. 2. Mast cells in the normal gingiva (a – at 900x magnification). Massive degranulation of mast cells of the lamina propria in a patient 
with mild inflammation (b – 200x); massive accumulation of mast cells in severe gingivitis (c – 400x); concentration of mast cells close 
to the epithelium (d – 400x); intraepithelial mast cells. Note their location in the intermediate and superficial layers (e – 400x). Intraepi-
thelial mast cells, detail (f – 900x). Anti-mast cell tryptase, DAB.806 RAMONA AMINA POPOVICI ET AL.
find a significant relationship to the severity of the 
inflammatory infiltrate (Table 2). The location, types 
and density of MCs in the normal gingiva and peri-
odontal disease are shown in Fig. 2.
DISCUSSION
MCs develop from myeloid progenitors under the 
influence of stem cell factor and they are widely dis-
tributed in the connective tissue and mucosal sur-
faces. MCs play a crucial role in host defense and 
homeostasis, and are involved in many pathological 
conditions,  such  as  inflammation  and  tumor  pro-
gression. Degranulation induced by MC activation 
releases pro-inflammatory substances, like proteases, 
histamine, proteoglycans, arachidonic acid metabo-
lites, chemokines and growth factors. From cytokines 
secreted by the mast cell, tumor necrosis factor alpha 
is of particular interest, being related to inflamma-
tion of the oral cavity (Walsh et al., 1995). MCs form 
a heterogeneous system and they are stratified on the 
basis of their content in proteases (Irani et al., 1986; 
Fonzi et al., 1995). Mast cell tryptase is expressed 
virtually by all mast cell subtypes and this is why 
we have chosen the specific immunohistochemical 
method to detect this highly specific MC marker. 
Gingiva is the site in the oral cavity that contains 
the highest number of MCs and they were investi-
gated in both normal and pathological conditions 
by many authors (Fonzi et al., 1996; Kennett et al., 
1993;  Allam  et  al.,  2008).  Their  density  does  not 
seem to be influenced by systemic therapy, such as 
antiretroviral drugs or immunosuppressive therapy 
(Segundo et al., 2012; Nurmenniemi et al., 2004). 
MCs of the gingiva are sensitive not only to chemi-
cal substances, but also to physical agents, like metal 
ions or low-intensity laser irradiation that induces 
massive degranulation (Schedle et al., 1998; Silveira 
et al., 2008). 
Mast cell reaction has been investigated in peri-
odontal disease by many authors and conflicting re-
sults have been reported (Lagdive et al., 2013; Stein-
svoll et al., 2004; Batista et al., 2005; Gemmell et al., 
2004).  Some  authors  found  a  decreased  mast  cell 
density, while others noticed a significant increase. 
In none of these studies was the MC number corre-
lated with the density and distribution of the inflam-
matory  infiltrate.  We  found  a  significant  increase 
of  mast  cell  density  in  patients  with  periodontal 
disease in comparison to healthy gingiva. This was 
particularly evident in cases with mild and moder-
ate inflammation, followed by a significant decrease 
in cases with severe periodontal disease. This finding 
might be explained on the one hand by the higher 
rate of degranulation, and on the other by the mi-
gration of MCs into the epithelium. Recently, Huang 
Table 1. Distribution of cases based on the scoring of the inflammatory infiltrate and mast cell density
Score Inflammatory infiltrate Mast cell density Minimum Maximum 
No inflammation (n=12) 0 20.12 12 31
Mild (n=17) +1 44.08 19.5 65
Moderate (n=9) +2 63.87 42 97
Severe (n=13) +3 33.81 26 53
Table 2. Mast cell density versus degranulated MCs and intraepithelial MCs
Lesion/Degranulation rate MCD/D-MCs Intraepithelial MCs
No inflammation (n=12) 20.12/6.5 (3.09) 0
Mild (n=17) 44.08/18.08 (2.43) 6/17 (35.29%)
Moderate (n=9) 63.87/23.25 (2.74) 5/9 (55.55%)
Severe (n=13) 33.81/13.76 (2.45) 12/13 (92.30%)
Legend: MCD, mast cell density; D-MCs, degranulated mast cellsMAST CELLS IN PERIODONTAL DISEASE 807
et al. (2013) found a gradual increase in the number 
of MCs from healthy gingiva to severe gingivitis. We 
cannot confirm this finding as we found a significant 
decrease of MCD in cases with severe inflammation. 
The difference might be explained in part by the dif-
ferent counting method, and only moderate and se-
vere periodontitis were included in the study.
Another  possible  explanation  for  the  decrease 
in MCD in cases with severe inflammation could be 
related to the multiple functions of these cells. Most 
probably,  MCs  in  periodontal  disease  govern  not 
only recruitment of inflammatory cells, but also the 
formation of new blood vessels. The involvement of 
MCs in the induction and maintaining of angiogen-
esis and lymphangiogenesis was already demonstrat-
ed in both clinical and experimental conditions. This 
is supported by the expression of vascular endothe-
lial growth factor by epithelial cells of the oral mu-
cosa and the increased microvessel density in patho-
logical conditions (Michailidou et al., 2012). Based 
on these data, we can suggest that the increase in the 
MC number is an early event during the progression 
of inflammatory changes in the gingiva.
Intraepithelial MCs were first reported in the li-
chen planus of the gingiva by ultrastructural exami-
nation, and at that time it was suggested that they 
might be in an early stage of differentiation (Barnett, 
1975). Intraepithelial MCs have been also reported 
in other inflammatory diseases, like active Helico-
bacter pylori gastritis (Caruso et al., 2011) or in pa-
tients with asthma (Laitinen et al., 1993; Gibson et 
al.,  1993).  They  were  also  found  in  intraepithelial 
neoplasia, recognized as a diagnostic tool and seem 
to promote progression to invasive carcinoma (Van 
de Nieuwenhof et al., 2010). In the present study, we 
found intraepithelial MCs only in cases with peri-
odontal disease with a gradual increase in number 
with the severity of inflammation (from 35.29% in 
cases with mild to 92.3% in cases with severe inflam-
matory changes). Our results suggest that intraepi-
thelial MCs can be useful to evaluate the severity of 
periodontal disease because we found a linear rela-
tionship with the density of the inflammatory infil-
trate.
The migratory potential of MCs has been already 
demonstrated and seems to be stimulated by the mast 
cell growth factor. Mast cell growth factor is secreted 
by endothelial cells and cells of the covering epithelia 
and stimulates the homing of MC precursors into the 
epithelia (Walsh, 2003). The expression of mast cell 
growth factor is not modified by degranulation and 
this  explains  the  accumulation  of  numerous  MCs 
close to or within the epithelium in inflammatory 
conditions. 
The presence and role of MCs in the epithelium 
of the gingiva is difficult to explain, despite the pres-
ence of scattered MCs with degranulation. Although 
the significance of intraepithelial MCs remains to be 
clarified, in an experimental model of MCs and epi-
thelial cells from the corneas of patients with kera-
toconjunctivitis, a particular relationship was found. 
CCL2  protein/mRNA  expression  was  induced  by 
co-culture, with upregulation in MCs and CCL2 ex-
pression induced in the epithelial cells, with subse-
quent degranulation of MCs (Iwamoto et al., 2013). 
An increased number of endobronchial intraepithe-
lial MCs was found in a clinical study performed on 
patients with asthma and a particular protease phe-
notype (tryptase and carboxypeptidase A3 high and 
chymase low) has been demonstrated by gene analy-
sis (Dougherty et al., 2010). The protease spectrum 
of these intraepithelial MCs was found predictive for 
the response to corticoid therapy, and Il-13-stimu-
lated production of stem cell factor by epithelial cells 
might explain MCs accumulation within the epithe-
lium (Günhan et al., 1991).
CONCLUSION
Our  results  demonstrate  a  significant  increase  in 
mast cell density in patients with periodontal dis-
ease compared with healthy controls. This is associ-
ated with a significant increase of the degranulation 
rate. Accumulation of mast cells in the epithelium 
was found only in patients with periodontal disease 
and their density strongly correlated with the degree 
of  inflammation.  Morphological  and  immunohis-
tochemical data concerning the correlation of MCs 
with  inflammation  in  human  periodontal  disease 808 RAMONA AMINA POPOVICI ET AL.
point to the necessity of a critical reassessment of 
periodontal disease treatment which is followed by 
the use of mast cell stabilizing agents as an adjuvant 
therapy for gingival pathology.
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